Immitra Bio GmbH
PrivateLast Round
Pre Seed
Jul 21, 2026
Est. Valuation
$22M
Total Funding Raised
$3M
Company Overview
Immitra Bio GmbH is a biotechnology company that develops an in-vivo gene editing platform combining hematopoietic stem cell manipulation and CRISPR-Cas9 technology to treat rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immitra Bio GmbH Comparables
Compare Immitra Bio GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensoma | 78% | |
| YolTech Therapeutics | 75% | |
| Tessera Therapeutics | 73% | |
Immitra Bio GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 21, 2026 |
Immitra Bio GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Pre Seed |
| Fongit | Pre Seed |
| BackBone Ventures | Pre Seed |
| ETH Zurich Foundation | Pre Seed |
| Venture Kick | Pre Seed |
| another.vc | Pre Seed |
| OCCIDENT | Pre Seed |
Immitra Bio GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immitra Bio GmbH's valuation, stock price, and market status.